These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 16339844)

  • 21. Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms.
    Stickler DJ
    Symp Ser Soc Appl Microbiol; 2002; (31):163S-170S. PubMed ID: 12481841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens.
    Chew BH; Cadieux PA; Reid G; Denstedt JD
    J Endourol; 2006 Nov; 20(11):949-58. PubMed ID: 17144870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against
    Kart D; Kustimur AS; Sağıroğlu M; Kalkancı A
    Balkan Med J; 2017 Dec; 34(6):546-552. PubMed ID: 29215338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations on the adherence of Proteus mirabilis onto polymer surfaces.
    Stickler DJ; Lear JC; Morris NS; Macleod SM; Downer A; Cadd DH; Feast WJ
    J Appl Microbiol; 2006 May; 100(5):1028-33. PubMed ID: 16630003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.
    Darouiche RO; Mansouri MD; Gawande PV; Madhyastha S
    J Antimicrob Chemother; 2009 Jul; 64(1):88-93. PubMed ID: 19447791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A sensor to detect the early stages in the development of crystalline Proteus mirabilis biofilm on indwelling bladder catheters.
    Stickler DJ; Jones SM; Adusei GO; Waters MG
    J Clin Microbiol; 2006 Apr; 44(4):1540-2. PubMed ID: 16597888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters.
    Sabbuba N; Hughes G; Stickler DJ
    BJU Int; 2002 Jan; 89(1):55-60. PubMed ID: 11849161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Virulence factors in Proteus spp. bacteria isolated from urinary tract infections: their detection and importance].
    Klin Mikrobiol Infekc Lek; 2011 Aug; 17(4):129-34. PubMed ID: 22052099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves.
    Hazan Z; Zumeris J; Jacob H; Raskin H; Kratysh G; Vishnia M; Dror N; Barliya T; Mandel M; Lavie G
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4144-52. PubMed ID: 16940055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urinary catheter biofilm infections].
    Holá V; Růzicka F
    Epidemiol Mikrobiol Imunol; 2008 Apr; 57(2):47-52. PubMed ID: 18578409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural stages of biofilm development of Escherichia coli on urethral catheters and effects of antibiotics on biofilm formation.
    Koseoglu H; Aslan G; Esen N; Sen BH; Coban H
    Urology; 2006 Nov; 68(5):942-6. PubMed ID: 17113884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm.
    Chiappetta DA; Degrossi J; Teves S; D'Aquino M; Bregni C; Sosnik A
    Eur J Pharm Biopharm; 2008 Jun; 69(2):535-45. PubMed ID: 18194853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Biofilm Effect of Octenidine and Polyhexanide on Uropathogenic Biofilm-Producing Bacteria.
    Loose M; Naber KG; Purcell L; Wirth MP; Wagenlehner FME
    Urol Int; 2021; 105(3-4):278-284. PubMed ID: 33401282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation.
    Ferrières L; Hancock V; Klemm P
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):212-9. PubMed ID: 17645737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of quorum sensing antagonists to deter the formation of crystalline Proteus mirabilis biofilms.
    Jones SM; Dang TT; Martinuzzi R
    Int J Antimicrob Agents; 2009 Oct; 34(4):360-4. PubMed ID: 19619987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some observations on the migration of Proteus mirabilis and other urinary tract pathogens over foley catheters.
    Williams GJ; Stickler DJ
    Infect Control Hosp Epidemiol; 2008 May; 29(5):443-5. PubMed ID: 18419368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of triclosan on Salmonella typhimurium at different growth stages and in biofilms.
    Tabak M; Scher K; Hartog E; Romling U; Matthews KR; Chikindas ML; Yaron S
    FEMS Microbiol Lett; 2007 Feb; 267(2):200-6. PubMed ID: 17156099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.